Supply Chain Vulnerability & Geopolitical Risks - The industry acknowledges the fragility of global supply chains, particularly concerning reliance on China and Russia [2][3][4] - China's use of export controls on critical minerals like rare earths, gallium, and antimony poses a coercive threat to the United States [3] - Russia's actions regarding uranium stocks also present a potential risk to the US [3] Reshoring & Domestic Manufacturing - Major drug manufacturers have announced multi-billion dollar investments to build manufacturing facilities in the US [5] - The administration supports incentivizing domestic manufacturing through measures like tax incentives [5] - An executive order aims to establish price floors through long-term demand contracts, similar to the strategy used with rare earths, to protect domestic producers from unfair dumping by foreign countries [7] Tariffs & Trade Policy - Concerns exist that tariffs may raise costs for drug manufacturers and hinder their ability to profitably establish domestic production [6] - The executive order seeks to counter the practice of foreign countries, particularly China and India, dumping capacity product into US markets [7] Government Intervention & Emergency Response - The government demonstrated the ability to rapidly establish domestic production capabilities during the pandemic, such as ventilator factories in 14 days [9] - The administration emphasizes the importance of protecting American manufacturers [9]

MP Materials' success in rare earths shows what a partnership with the government can do for critical materials, @tomwblack says (via @opinion) https://t.co/KyFSu7l2md ...